Company
Invenra
Antibody Discovery Made Simple
Also known as Invenra Inc
- Business model
- B2B
- Legal name
- Invenra Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Discovers novel multispecific antibodies to treat cancer and immunological diseases
Funding snapshot
- Total raised
- $21.3MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $7.1M2018-10-01
Funding rounds
- Round, 2018
- $7.1M2018-10-01, SEC form D sold, 23 investors
- Round, 2017
- $2.9M2017-09-20, SEC form D sold, 25 investors
- Round, 2016
- $3M2016-07-12, SEC form D sold, 27 investors
- Round, 2015
- $2M2015-08-13, SEC form D sold, 28 investors
- Round, 2015
- $2M2015-01-14, SEC form D sold, 25 investors
- Round, 2013
- $3M2013-02-08, SEC form D sold, 26 investors
- Round, 2012
- $1.2M2012-01-06, SEC form D sold, 18 investors
Loading relationship preview